三叉神经痛的治疗失败:从三叉神经躯体定位的阐明到靶向部分感觉神经根切断术
该回顾性连续病例研究纳入2000年3月至2015年6月在本机构治疗的22例无血管压迫的药物难治性三叉神经痛成人患者,采用基于三叉神经躯体定位精准图谱的靶向部分感觉神经根切断术(TPSR)。结果显示86.4%的患者疼痛完全缓解,术后部分性局灶性感觉减退发生率为22.7%,5年复发率为31.5%(标准差10.9%)。作者认为TPSR是治疗无血管压迫的药物难治性三叉神经痛的其他毁损手术的有趣替代方案。
要点
- 22例无血管压迫的药物难治性三叉神经痛患者接受TPSR,完全疼痛缓解率为86.4%。
- 术后感觉减退为部分性且局灶性,发生率为22.7%。
- 5年三叉神经痛复发率为31.5%(标准差10.9%)。
核心结论
- 作者阐明了三叉神经近脑桥段的功能性躯体定位。
- 作者认为TPSR是治疗无血管压迫的药物难治性三叉神经痛的其他毁损手术的有趣替代方案。
研究设计与样本
- 回顾性连续病例研究,纳入2000年3月至2015年6月在本机构治疗的药物难治性三叉神经痛且无血管压迫的成人患者。
- 手术采用三叉神经躯体定位精准图谱进行靶向部分感觉神经根切断术(TPSR)。
- 共22例患者接受TPSR,其中14例为无神经根压迫的特发性三叉神经痛,6例为多发性硬化所致的继发性三叉神经痛,2例为不可手术肿瘤导致的三叉神经冲突。
- 研究者将结果与其他手术及非手术治疗进行了比较。
主要发现
- 86.4%的患者获得完全疼痛缓解。
- 术后感觉减退为部分性且局灶性,发生率为22.7%。
- 5年三叉神经痛复发率为31.5%(标准差10.9%)。
临床怎么用
- 作者认为TPSR是治疗无血管压迫的药物难治性三叉神经痛的其他毁损手术的有趣替代方案。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Trigeminal neuralgia (TN) is a severe unilateral facial pain involving 1 or more branches of the trigeminal nerve (CNV). Microvascular decompression is a standard curative treatment of pharmacoresistant classic TN. Alternative procedures used for secondary or idiopathic TN usually lead to a high rate of pain recurrence and sensitive deficits. Partial sensory rhizotomy (PSR) is one of these ablative procedures. However, the lack of anatomic knowledge about the somatotopy of CNV lead to variable results in pain relief and hypoesthesia. OBJECTIVE: To refine the somatotopy of CNV and bring new anatomic landmarks for PSR, studying a cohort of patients treated by a targeted PSR (TPSR). METHODS: Retrospective and consecutive cases of adult patients treated in our institution between March 2000 and June 2015 for pharmacoresistant TN without vascular compression were collected. Our surgical procedure was performed using a precision map of the somatotopy of CNV. We compared our results with other surgical and nonsurgical therapies. RESULTS: Twenty-two patients had undergone TPSR. Fourteen had an idiopathic TN without compression of the nerve root, 6 had a secondary TN caused by multiple sclerosis, and 2 had a trigeminal conflict by inoperable tumor. Complete pain relief was achieved in 86.4% of the patients. Postoperative hypoesthesia was partial and focalized (22.7%). TN recurrence rate at 5 years was 31.5% (standard deviation, 10.9%). CONCLUSIONS: We clarified the functional somatotopy of CNV in its juxtapontine portion. TPSR is an interesting alternative to other ablative procedures to treat pharmacoresistant TN without vascular compression.
引用
- Terrier LM, Amelot A, François P, et al. Therapeutic Failure in Trigeminal Neuralgia: from a Clarification of Trigeminal Nerve Somatotopy to a Targeted Partial Sensory Rhizotomy. World Neurosurg. 2018. PMID: 29883821. doi:10.1016/j.wneu.2018.05.211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。